Medicenna Therapeutics (MDNA) Granted US Patent for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Medicenna Strengthens IP Portfolio with U S Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.